LC8A Stock Forecast - Calliditas Therapeutics AB

	Calliditas Therapeutics AB F:LC8A	SE
E	Encavis AG XMUN:ECV	DE
H	Havilah Resources Ltd F:FWL	AU
S	sino AG DUS:XTP	DE
	OSB Group PLC F:2UK	UK
K	Kingdee International Software Group Co Ltd XMUN:KDIC	CN
D	Dongfeng Motor Group Co Ltd SWB:D4D	CN

Wall St Price Targets

There are no price targets for LC8A.

LC8A Lowest Forecast

LC8A Average Forecast

LC8A Highest Forecast

Pacific Biosciences of California Inc

65% Upside

First Community Bankshares Inc

-6% Downside

Pacific Biosciences of California Inc

65% Upside

First Community Bankshares Inc

-6% Downside

Revenue
Forecast

N/A

Past Growth

57% / Year

Estimated Growth

Estimates Accuracy

4%

Average Beat

N/A

Past Growth

57% / Year

Estimated Growth

Estimates Accuracy

4%

Average Beat

The compound annual growth rate for Revenue over the next 3 years is 57%.

What are analyst estimates?

Gross Profit
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Operating Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-17%

Average Miss

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-17%

Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Net Income
Forecast

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

N/A

Past Growth

N/A

Estimated Growth

N/A

Estimates Accuracy

N/A

Average Beat/Miss

Continue LC8A Research

Summary

DCF Valuation

Relative Valuation

Wall St Estimates

Profitability

Solvency

Financials

Discount Rate

NASDAQ • USD

CALT

STO • SEK

CALTX

F • EUR

LC8

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

LC8A does not have any price targets made by Wall Street professionals.

The compound annual growth rate for Revenue over the next 3 years is 57%.

Back to Top

Calliditas Therapeutics AB
F:LC8A

Wall St Price Targets

LC8A Price Targets Summary
Calliditas Therapeutics AB

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

Continue LC8A Research

What is LC8A's stock price target?

Not Available

What is the Revenue forecast for Calliditas Therapeutics AB?

Projected CAGR
57%

Company

Help

Tools

Stocks

Calliditas Therapeutics AB F:LC8A

Wall St Price Targets

LC8A Price Targets Summary Calliditas Therapeutics AB

Revenue Forecast

Gross Profit Forecast

Operating Income Forecast

Pre-Tax Income Forecast

Net Income Forecast

Continue LC8A Research

What is LC8A's stock price target? Not Available

What is the Revenue forecast for Calliditas Therapeutics AB? Projected CAGR 57%

Company

Help

Tools

Stocks

Calliditas Therapeutics AB
F:LC8A

LC8A Price Targets Summary
Calliditas Therapeutics AB

Revenue
Forecast

Gross Profit
Forecast

Operating Income
Forecast

Pre-Tax Income
Forecast

Net Income
Forecast

What is LC8A's stock price target?

Not Available

What is the Revenue forecast for Calliditas Therapeutics AB?

Projected CAGR
57%